In this edition of Ideas for Profit, Moneycontrol's Sakshi Batra will share more details about this company and whether investors should keep an eye on it
Amid the novel coronavirus outbreak, there is one micro-cap company that has emerged at the frontline in the war against the COVID-19 attack. This company has been fuelling growth with its foray into the medical devices business. Current approval for production of real-time polymer chain reaction detection kits for COVID-19 would provide a further boost. The stock has seen a substantial correction in the last few weeks and commands attention.
In this edition of Ideas for Profit, Moneycontrol's Sakshi Batra will share more details about this company and whether investors should keep an eye on it.
To track all live updates from the coronavirus pandemic, click here…Follow our full coverage of the coronavirus pandemic here…
Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
First Published on Apr 3, 2020 08:30 pm
